Velphoro 500 MG chewable tab 90S
Ended Awarded
- Contract number
- SPE2DB26FL4A3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,386
Award facts
- Contract value 100% obligated
- $22,386.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $22,386.23 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Velphoro 500 mg chewable tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of October 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's contract portfolio with the Defense Logistics Agency demonstrates extensive capabilities in supplying specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This particular award for Velphoro, a phosphate binder medication used in renal disease management, exemplifies the company's role in supporting military and veteran healthcare pharmaceutical needs through the DLA's Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DB26FL4A3?
SPE2DB26FL4A3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FL4A3 worth?
The government has obligated $22,386 on SPE2DB26FL4A3.
Is contract SPE2DB26FL4A3 an order under another contract?
Yes. SPE2DB26FL4A3 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB26FL4A3 competed?
The extent of competition for SPE2DB26FL4A3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award